Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

NCT07177482

Conditions: Craniopharyngioma, Disease, Neoplasms, +6 more
Locations: Beijing Tiantan Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

NCT07141732

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Joint-Stock Company European Medical Center Moscow, Russia

View Trial Details

Recruiting

ALG-LungCancerRegistry (SAFRO2202)

NCT07161882

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoid Tumor, +17 more
Locations: Centre Pierre et Marie Curie Algiers, Algiers Province, Algeria

Chu Beni Messous - Isaad Hassani Algiers, Algiers Province, Algeria

CHU Mohamed Lamine Debaghine - Bab-el-Oued Algiers, Algiers Province, Algeria

Chu-Beni Messous - Isaad Hassani Algiers, Algiers Province, Algeria

View all 21 locations

View Trial Details

Recruiting

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

NCT06577987

Conditions: Adenocarcinoma, Advanced Solid Tumor, Breast Diseases, +30 more
Locations: Florida Cancer Specialists Sarasota, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

START Midwest Grand Rapids, Michigan, United States

Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

View Trial Details

Recruiting

Registering Genomics and Imaging of Tumors (ReGIT)

NCT05386043

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Indiana University School of Medicine Indianapolis, Indiana, United States

View Trial Details

Recruiting

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

NCT07167329

Conditions: Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +44 more
Locations: AC Camargo Cancer Center São Paulo, Brazil

View Trial Details

Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

NCT04511013

Conditions: Acral Lentiginous Melanoma, Brain Diseases, Brain Neoplasms, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

View all 331 locations

View Trial Details

Recruiting

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

NCT03454035

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

NCT06552260

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

NCT05387603

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Sahlgrenska University Hospital, Dept. of Oncology Gothenburg, Sweden

Skåne University Hospital, Dept. of Oncology Lund, Sweden

Karolinska University Hospital, Dept. of Oncology Stockholm, Sweden

Accademical Hospital, Uppsala, Dept. of Oncology Uppsala, Sweden

View Trial Details